NCT06447441View on ClinicalTrials.gov

Clinical Outcomes Of Mega-dosage Supplementations Of Cholecalciferol In Critically Ill Patients With Sepsis

NANot yet recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 1, 2027

Study Completion Date

December 31, 2029

Conditions
Critically IllSepsisMortality RateCritical Care
Interventions
OTHER

Placebo

Enteral supplementation of placebo in 3 consecutive days within 96 hours after ICU admission.

OTHER

Cholecalciferol

Enteral supplementation of 576,000IU/day vitamin D3 in 3 consecutive days within 96 hours after ICU admission

Sponsors
All Listed Sponsors
collaborator

E-DA Hospital

OTHER

lead

Chimei Medical Center

OTHER